Validation of a predictive model for coronary artery disease in patients with diabetes

Junhong Xu1, Qiongrui Zhao2, Juan Li3

  • 1Department of Clinical Microbiology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, Henan.

Insights

A new model effectively predicts coronary artery disease (CAD) in diabetes patients. Key predictors include sex, diabetes duration, and lipid levels, offering improved risk assessment for this population.

Area of Science:

  • Cardiology
  • Diabetology
  • Predictive Modeling

Background:

  • Current models for predicting coronary artery disease (CAD) in diabetic patients lack reliability.
  • Developing a dependable predictive model for CAD in diabetes is a critical unmet need.

Purpose of the Study:

  • To develop and validate a predictive model for coronary artery disease (CAD) occurrence specifically in patients with diabetes.
  • To identify key clinical and laboratory predictors of CAD in this high-risk population.

Main Methods:

  • Retrospective enrollment of 1390 diabetes patients from Henan Provincial People's Hospital.
  • Development of a predictive model using univariate and multivariate logistic regression on a training set (n=1152).
  • Validation of the model's performance using Area Under the Curve (AUC) and Brier scores on a separate validation set (n=238).

Main Results:

  • Identified significant predictors of CAD in diabetes patients: sex, diabetes duration, low-density lipoprotein, creatinine, high-density lipoprotein, hypertension, and heart rate.
  • The developed model achieved an AUC of 0.753 in the training set and 0.738 in the validation set.
  • Brier scores were 0.152 (training) and 0.172 (validation), indicating favorable model performance.

Conclusions:

  • The developed predictive model demonstrates favorable performance in identifying patients with diabetes at risk of CAD.
  • This model offers a valuable tool for effectively predicting CAD occurrence in the diabetic population.
  • The identified predictors can aid clinicians in risk stratification and early intervention strategies.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
24
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
23
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
24